Article
Analysis of hepatitis C NS5A resistance associated polymorphisms using ultra deep single molecule real time (SMRT) sequencing.
Antiviral research - 1 Feb 2016
Bergfors Assar, Leenheer Daniël, Bergqvist Anders, Ameur Adam, Lennerstrand Johan
Abstract excerpt
Development of Hepatitis C virus (HCV) resistance against direct-acting antivirals (DAAs), including NS5A inhibitors, is an obstacle to successful treatment of HCV when DAAs are used in sub-optimal combinations. Furthermore, it has been shown that baseline (pre-existing) resistance against DAAs is present in treatment naïve-patients and this will potentially complicate future treatment strategies in different HCV...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
